!G=C>?:#A<DC<I8GNA>Dbkkba‚ƒL;;G„…†lc‡lˆ
`
`   
`   

 

 



  
`



       

 
`
` ! "!#$%!
`&  

'

 

()*+ , -    .

  /     *0 * 1   
`
`2344567
`
` 89:;<:=>?:9@=:A=?B<CC<:8DEF8@>GH=9><9>I<?F>
`C<?<J>H@=:AI8?K>?:=8?<G=CCL?89L;;D>99=K>:A>DM
`<;ENA>IA8=I>8O<J>?:9:8;D>K>?:D>G<;9>98O=?B<CM
`C<:8DEF8@>GH=9><9>CL9:F>F<9>H8?>OPI<IE:8Q=I=:E
`<?HI89::LH=>9=?<?=C<GC8H>G98O=?B<CC<:8DEF8@>G
`H=9><9>=?H=I<:>:A<:IAD8?=I=?:>9:=?<G=?B<CC<:=8?
`D>9LG:9OD8C>?A<?I>H=CCL?>D>9;8?9>9:8F<I:>D=<:A<:
`<D>;D>9>?:?8DC<GGE=?:A>GLC>?R8998O:8G>D<?I><?
`<F?8DC<GOL?I:=8?8DH>O>I:=K>A><G=?J8O:A>CLI89<G
`F<DD=>DC<E<GGJ=K>D<=9>:8IAD8?=I=?:>9:=?<G=?B<CC<M
`:=8?NA=9AE;8:A>9=9=9:A>F<9=98O?>@:A>D<;=>9<=C>H
`<:>=:A>DH>ID><9=?J :A>G>K>G98OGLC=?<GF<I:>D=<G
`<?:=J>?9<?HS8D9>G>I:=K>GEFG8IT=?JH>:D=C>?:<GCLI89<G
`=CCL?>D>9;8?9>9!?:=MN$U=9<?>Q<C;G>8O:A=9?8K>G
`
`<;;D8<IA:A<:=9K>DE>OO>I:=K>=?VD8A?W9H=9><9>NA>L9>
`8OF=8G8J=I<G:A>D<;E=9I89:GEA8@>K>D<?H:A>G8?JM
`:>DC I8C;G=I<:=8?9<D>?8:E>:T?8@?NA>D>I>?:
`=?ID><9>8O:LF>DILG89=9=?;<:=>?:9:D><:>H@=:A<?:=M
`N$U=?H=I<:>9:A<:I<D>OLGC8?=:8D=?J=9?>I>99<DEX:=9
`IG><D:A<::A>?>@ O8DC98O:D><:C>?:C<E;G<E<?
`=C;8D:<?:D8G>=?:<=G8D=?J:A><;;D8;D=<:>HDLJ:8<
`9;>I=PIJD8L;8O;<:=>?:9Y8@>K>DO8D:A>:=C>F>=?J
`P?>M:L?=?J=?:A>L9>8OI8?K>?:=8?<G=CCL?89L;;D>9M
`9=8?=9?>I>99<DE$>@ T?8@G>HJ>=?:A>;A<DC<I8J>M
`?>:=I98O:A>9>I8C;8L?H9<GG8@9=C;D8K>C>?:9:8F>
`C<H>=?:A>=DL9>X:=9:8F>A8;>H:A<:<ID=:=I<G<;;D8<IA
`=? :A>L9>8OILDD>?:<?HOL:LD>HDLJ9:<T=?J=?:8
`<II8L?::A><HK<?I>9=?:A><>:=8;<:A8J>?>9=98O=?B<CM
`C<:8DEF8@>GH=9><9>@=GGI8?:D=FL:>:8:A>ZL<G=:E8OG=O>
`8O;<:=>?:9@=:A=?B<CC<:8DEF8@>GH=9><9>
`
`[\]6^_3`][^\
`
`X?:A><F9>?I>8O<H>P?=:=K>ILD>O8DVD8A?W9H=9><9>
`:A><=C 8O:A>D<;E=9:8=?HLI><?HC<=?:<=?IG=?=I<G
`D>C=99=8?<:<?<II>;:<FG>I89::8:A>;<:=>?:=?:>DC98O
`<HK>D9>>OO>I:9<?HI89:9:8:A>A><G:A9E9:>CNA>PD9:M
`G=?>:D><:C>?:O8DVD8A?W9H=9><9>=99:=GGF<9>H 8?
`a
`I8CF=?<:=8?98OJGLI8I8D:=I89:>D8=H9
`<C=?8M9<G=IEG=I
`<I=H H>D=K<:=K>9>?:>D<G?L:D=:=8? <?H 8II<9=8?<GGE
`;<D>?:>D<G?L:D=:=8?<GD>J=C>?9NA>D>I>?:>Q;G89=8?
`=? T?8@G>HJ>8O=?B<CC<:8DE C>IA<?=9C9<?H :A>
`A=JA=?I=H>?I>8O:8Q=I=:E@=:A;D8G8?J>H9:>D8=HL9>
`:8J>:A>D@=:A:A>O<I::A<:I8?:D8GG>H:D=<G9A<K>IG><DGE
`
`

 

  

`m

n0nonm p*+ , -    /     *
`mqr

stuvt*wuut/r0 * 1   n
`xy
`n zn
`'nr

 





) & 0 )

o  n{ 

|
`

  })(

 



 ~






`0  ~0€n
`
`9A8@?:A<:JGLI8I8D:=I89:>D8=H9H8?8:C<=?:<=?D>C=9M
`b
`9=8?
`@<DD<?:9<D<:=8?<G<;;D8<IA:8:A>IA8=I>8O
`?>@>D<?HG>99@>GG:>9:>H:A>D<;>L:=I<;;D8<IA>9=?
`:A89>;<:=>?:9@A8<D>?8:D>9;8?H=?J>OO>I:=K>GE:8:A>
`c
`9:<?H<DH:D><:C>?:
`X?:A=9;<;>D@>9>:8L:<ID=:=I<G<;;D8<IA:8:A>
`?>@>DO8DC98O:D><:C>?:=?:A>C<?<J>C>?:8O9>K>D>
`I<9>98OIAD8?=I=?B<CC<:8DEF8@>GH=9><9>
`
`d^5e2^f45\5dg4g\]^f[\fe5445]^67
`h^ige_[2g52g
`
`NA>J8<G98OC<?<J>C>?:<D>:8=C;D8K>8DC<=?:<=?
`ZL<G=:E8OG=O>NA=9I<?F><IA=>K>HFE=C;D8K>C>?:
`8D;D>K>?:=8?8O9EC;:8C9<K8=H<?I>8O9=H>M>OO>I:9S
`<HK>D9>>K>?:9<?H<H>ID><9>=?I8C;G=I<:=8?9U=?<GGE
`<?H8OJD><:=C;8D:<?I>:8:A>;<:=>?:<?=C;8D:<?:
`J8<G=9:8<K8=H9LDJ>DE
`
`j bkkbG<IT@>GGI=>?I>R:H
`
`lc
`
`

`

`<; V%:WWXWY:Z[\]^
`
`    
`
`
`


`
`  
`
`   
`
`  

! 
` 

`"
`#$  %&
` 

 
`
` 



  
` "
`  
` 

%'
`
` 
`
`$ 
`
` 
`  

 
`
`
` 

%(
`  #)**)
`
`
`

 ! 
` "
`
` 

"+%, 
`+  
`- 
`. 
`+
`  
`   "
`  %
` / 
`



 
`
`
` 
`

    0
`

 


` 


`  
` 
`
` %1

  
` 
`
`

 

`
`
`
`%2
`
` 




`


`  %
`
` 3453567 6 68  6787
`
`9  
` /
`   
` 


`  


`%
`:  
`
` 
` 
`
`

  $
`
` 

 
` "
`
`

 
`  
` 
`   
` 

%
`
` 
`!
`   
`
`

 - 
`.
` 
`  

  
`
` %1
`       "
`;<
`0


` %
`'   


`   


`

  
` 

%
`
` 856 6=33>?@5A 7575A8B
`5>C 7>D5== >6A 3  67
`
`  
` 
`    
` 

 
`  "
`  %'
`
`
`  


`
`  
` 
` 

%, $

` 
` 
`E
`  
`   "
` # #
`

 
` + 
`

 "'F    
`"
` 9,G1HI*F  

F 
`  %
`:
`    

 
`

 %
` 
`
`
`

+
`J:' 
`K
`
` +  %
`1 
`
` $     

 ! 
`
` 
` " 
`     
`
`! +   %
`
`+

 
`
`  
`L
`M
`   #

 
` 
` 
`
`P
`<"N<"':'O



 %
`1


`
`


`!
` 
`
`    
` 
`


`
` 


`
`  
`
` 

/
`
`

%- 
` 

 
`0 
` 
`

 
`<*QM*R 
`

%S
` 
`
` 

  
`


` 
` F
`  
`

    
`
`

  
` " %
`
` 
` 
`  
`
`"
` 
`
`  "
`
`
`

 
` 


` %
`1 

 "' 
`I*II
`  "  %
`1 "
`

 "'
`


` 
`    - 
`.
`!
`
`
` 

 
`  %1


`     "   
`I)
` %
`
`
` 

 "'
` 

- 
`.
` 
`

  

"
`

  
` 
`

! "

  0
`
`

%1  
` 
`"
` 

` 

   


`
`  

 
`

 

`  NS T
`U 


`O%
`+

 
`
` 
` 
`!#  - 
`.%V


`
`_ )**)20:H`]abZc[de\fb\gh]ieZfjkN:

%;O<lQ<M
`
`

`

`8NO,NPQ' 8,,'-'++8R'9 RNP R8:5R8N':N //
`
`   
`

`    
`
`  
`
` 
`
`
`  
` 
`
`  
`
`

`  


` 
`
`  
`   
`
`

   
` 
` 




`


` 
`  




`
` 
`

`    
`
`
`
` !
`
`
` 
`
`    
`


` 
` 
`
`"##$
` 


` !
`
` %
`  
`
`
`

 
`
` 
`

`   !
` 

 
`

&


`   
`


` 
`  




`
`
`  

 % 
`!'  
` 
`
` 

`   ($)  
`    
`"*"
` 
`
`!
`+
` 
`    
`
`
`

,-"$ 
`
` 
`
`
`
`

` 
`"/"0
`    
`.
`

`!
` 
`    
`
` 
` 
`
`
`
`'
`


`
`
` 
`
`
` 
`
`
` 
` 
` 
`
`
`
` 
`   
`
` 
`
`    
`
` 
`  
`
`
`
` 
`  

!
`
`
` 
`
`
`
` 
`

`
`
`  
`
`
`  


`
`
`
`

  


`
`
`
` 
`
`
`


`
`

   
`
` 
`  




` 

` 
`

 
`
` 
`

!
` 


` 


`
`
`
`  

` 
`

` 
` 
`
`
`

`  
`
`  


` 
`
`  
`    
` 
`
`
`     
` 
`  
`
`
`


` 
`
`

`
`!'


`




`  
`

  

1 2 1  .
` 21

'32  4
`

  
`1+/("2
`

  
`

`   
`
`  1
` 
`

` 2 
`
`
` 

`  
` 
`   

 
`
` 
`  & 
`
`"(
`  &

 
`      
`
`  
` !
`, 

` 
`

  
`
` 


`  
`
`  
`
`
`

` ! 
`   
` 
`
`    

 % 
`
`


`

   
`
`% "$1 ,-"$2
` ,-""  

`
`  
`


`"  
`
`
`  

` 
` 1,5,5 3*$32


`
`
` 
`
`
` &



    
`
` 
` 
`
`"6
` 

` 
`

 !
`5
`
`
`

` 
`  
`   


` 
`
`
`

 
`
`
`
`    
` 
`
`  

 
`!
`
`
`
` 
`7
`

 
`

 


` 
`
`
`
`
` 
`7
`

  
`  


`


`


` 
`
` 
`
`


`
` 
`

 
`  
`
`  
` 
` 
`  
` 

% 
`!
`
`
` 
`
` 
`
`

  
`
`  
`
` 


`
`
`  
` 
`

  
`

 
`"#3$
` 
`
`!
`'




` 


` 
` 
` 
`  
` 
`
`  
`
`
`   !8
` 4   




`.
`
`
`  
`
` 
` % 
` 
` 
`
` 
`
`
`  
`

` 
`

 
`
` 
`
` 
`
`  
`

` 
`
`
`
`
`   
`

`
` 
`
`

 
`
`
`


` 
` 
`
`
`
`
`    
`
` 
`
`!,
`
`
`    
`
`  
`
` 
`
`
`    
`
`
`
`
` 
`     
` 
`
`
`
`
`
` 
`
`9-' 
`

  !:
`
`
`
`
`


`

`
`


`  
` 
`

`
` 
`

   
` 
`
`
` !
`'  
`

 
`
`.  
`
`
`
`
` &



  
`       
` 
`
`-
`4
` 


`
` 
`
`
`
`






` &
`
`     
`
`
`
`%
`  
`
` 
`
`


`
`3"
`   !
`'
`
`  
`#
` 
`       
`
`
`
`
`
` 
`
`    
`
`"!/
`
`
`   !' 
`
`
` 
`
`     
` 

 

 
` 
`
` 
`
`
`
` 
`    
`

`
`   
`
`   
`        
`
`
` 
`
` 



 !
`
` 
` 

`

  
`
` 
`
`


`
` 
` 
`
`
`
`   
`
`!9
`
`
`
`  
`
`

`
`
`  
`  

`  
` 
`    4 


` 
` 
`  
`
`
`  &

 
` 

 
`  
`
`

`
`
`    
`
`
`
`33
`
`

`
` 
`
`


`!
`
`;<= >?@ABCDE?;FCC?=GHI=GJ?G@;KCFLHM
`
`, 
`  
`
`


` 
`


`
`   

`
`
` 
`
`

 !
`
`S 3$$3T

%
`5

`

`- UVWXYZ[\]^_X^`aVb]Y_cd15!2/*e/6
`
`

`

`I? ZWaa<a7Wbcdef
`
`       
`  

   
`  

        
`




`     


`   
`       

 
`
`    
`
`
`      
`
`     
`
`! "#!$$%&%"!'%() *!$+, () -+)('./+
`%$() '0+0(1%2()
`
`3    



 4


` 5      

 
` 

         
`  6 5
`    
`  


`

 

 5
`  

  

     
`  

    


`     5 

`    7


`8
`  
`

  5
`   
`
`9
`   5 

   5
` 
`   

  4   
` 5:;    5 

`      53    
`       
`

       4

 5  
` 
`  ;     
`  

    

  
`  
`<5     

5     
`

      

   
`   

= 

  = 
`         

 
` 

 5
`7    

  


`  
`;

  >   ?

  
`@?ABC
`      D5

 > 5
`  

 5    @BAC; ; 
` 
` 5;       5    
`
`5  ?    BA
`>5

   5
`  

  5  
`

 5
`     5 EFGE
`H  
`  5

 

 
`    5   : 
`BA  5

5

   
`AB  5

5 D       
`     
`35 

   
`   5  

   5 
`
`  



  BA   5
` 
`
`

  5 EFGE
`55
`I=J
`

  ?  

  
`   
`      


`  

 5
`  5 
`      K   
`    
`  
`  

5



  
`   6A5LLM
`  
`5       K   
`   5NOPQ
`  
`RSTPUVW 

    
`       K   
`    
`      @X77C6  

 
`M=8LY       K     
`

   9   

    
`    5   ;   
`

5
`   5    
`  

  6   :7Z  
`      
`
`    X77 ;MM 
`    XBW6  [\]  
` 5
`   X77 


`L=J
`[\]  5
`:     5
`

         4

 
`
`    

  ;5 5  
` ^      6   
` 

 

  
`
`           5
`
`    

       5
`       

  
`:    5      <_M
`  
`W

`
`  ;    4


`

 5  

  

 
`           
`W

` W

`  ;    
` 

    4

 5  
`


`8L=8
`      ; <_M
`   

5        5
`     9M   5

  
` <_M  B      

5
`       
`          
`
`,)! '+"0)(#(-.!), -+)+'1!)$&+1
`
`:            
` 

 4

 5   5
`  5:     
`       
`  
`
`g LL] W X
`SehibjcFkdlidmneEkblop@W8C
`I=Iq
`
`

`

`?;<;@ K? K!EE?OK= OM; O?(O ?; (;M /H
`
`   
` 



    
` 

 
`



  
`    
`
`  

      
`
`

   


` 

  
`
` 

    

`

 





`

  
`
` 

 
`
`  
` 




` 

   


` 
` 
`




`

 


`

  
`   




`    

    
`



   

  
`

  

  

`


` 
`     


`
`

  !"# 




` 

 
`

 



!"#
`
`  



  
`

 

    $

` 
` 


` 
`&' &&
`%

` 
`
` 



`


`
`  

% 

`

 
`


`




`

 
`
`



 (  
`

`     
`

 
`    
`


`)
`    
`


`
` 
`

  
`   



 
`


`   
`

 

`
`
`

  
` 
`

 
`
`
`  

  

*
`

  
` 



    
`   

  
`

  
`+##

  
`, 
` 

%    
`
`&/
`



 

-. 
`  
`

`,       
`
`








`   




`   
`
`
`
`0120345612
`
` 

 

   


`

  

   



 
` 

   

`

 

`

`   
`



` 


`
`

    

 
` 


`  

 

`


`
`     



  



 

`
`

 



  
`
` 
`  

 
` 

  
`

* 
`, 
`


` , 
`
`      


`

 

 
`

    



  
` 


`
`
`
`7898782085
`
`" 
` : ! 
`

;<: =

 >



?
` : 
` 

  

  
`    



@ 
` 



` 
`A

    +##"B"+"@+//CD#
`+ E

.==   
`

 

  
` 



F .

+###BD@&GC/HI


`

 
`/GJ
`' ?: F* E (?


`   



K?K!+##"B'G@
`''C"#G
`&  =L F
`% AEM
` 

`  K N






`
`KM   +##"BG"@"#'C"/ 
`/ ! K A

(M
`      
`



K
`OKM
`(K+###B'@''PC&&
`D N . ?

,   
`  
`
`,!+##"B'/G@"'GDCH
`H >( F

?  E( (L .( E
`(=
` 

 
`  

 


`
`
`  

   :E  ; 
`"PPPB+GP@"+&/CP
`G !, ?(   = ;

.E  ,


`% , 

%   A
`"PH'B"&@
`&+DCH
`P 

) A:?  

 


`   



F 
`

+##"B"/@''PC&P
`"# K ?. ? =
`F
`

 

 
`
`
` 

@  :A

  
`"PPPBP&@"/GHCP+
`"" !
` .  ;  
`  


`= 

    +###B&H@G'CP
`"+ =
`F  (F?

` K N






`

`

  
`
`


`

 

   :
`A

  "PP'BGG@D&DCP
`"'  .
` =(  .: = 

. QRSTU
`
`  K N





 
` 



 
`        I+J A

   
`"PP/B"#P@"+PC'/
`"& ? =
`F .: QRSTU


`

`       +
` 



`   K N





K N

.



+
`
`A
`M;:("PPHB''H@"#+PC'/
`
`V +##+F,! WTXYQZR[\S]YS^_T`\Q]abI
`&J /'C/G
`
`

`

`58
`D. SEEGERS etal.
` ) 

#

 23456
`
`15
`van Deventer SJ, Elson CO, Fedorak RN. Multiple doses of
`  
`

   
`intravenous interleukin 10 in steroid-refractory Crohn’s
`        !"
`disease. Crohn’s Dis Study Group Gastroenterol 1997; 113:
` !"  ##  $$%&'(
`383-9.
`')'*$
`16
`Colombel JF, Rutgeerts P, Malchow H,et al. Interleukin 10
`+  ,-
`./ !0 1234567 
`(Tenovil) in the prevention of postoperative recurrence of
`89 : !  
`Crohn’s disease. Gut 2001; 49: 42-6.
`!" #;&<$(<;*+
`17
`Present DH, Rutgeerts P, Targan S, et al. Infliximab for the
`% /1./9 .  234567=>, -!
`treatmentoffistulas in patients with Crohn’s disease. N Eng] J
` ,?  0!!" 

.
`
`Med 1999; 340: 1398-405.
`$$$&'<('$)*< 
`18
`Pena AS. What have we learned from the biological therapies
`) / @ A! ! 0  , !- . ! 
`in Ulcerative colitis? Editorial Am J Gastroenterol] 2001; 96:
`B   C

 @,
`#  ;&$+(
`1681-4.
`+)*<
`19
`Keane J, Gershon S, Wise RP, et al. Tuberculosis associated
`$ D 
`#! A/234569-   
`with infliximab, a tumor necrosis factor «neutralizing agent.
`0!=>, - , E F. .
`N Engl J Med 2001; 345: 1098-104.
`

.
`;&'< ($)*<
`20
`Nunez Martinez O, Ripoll Noiseux C, Cameros Martin JA,
`; F F >  
`@
`Gonzalez Lara V. Reactivation tuberculosis in a patient with
`#F FG  H  -   0!
`anti-TNE-« treatment. Am J Gastroenterol 2001; 96: 1665-6.
` 9E ,@,
`#  ;&$+(++ *+
`21
`Lopez-Cubero SO, Sullivan KM, McDonald GB. Course of
`; GF-     D  #I
`Crohn’s disease after allogeneic marrow transplantation.
`!"   . , 0    
`Gastroenterology 1998; 114: 433-40.
`#  . $$)&<(<''*<
`22
`James SP. Allogeneic bone marrow transplantation in
`;;
` , /@ . - , 0     
`Crohn’s disease. Gastroenterology 1998; 114: 596-8.
`!" #  . $$)&<( $+*)
`23
`Gasche C, Scholmerich J, BrynskovJ, et al. A simple classifi-
`;' # ! ! ,!
`I 
`23456@,  ?
`cation of Crohn’s disease: report of the Working Party for the
` !" (!A./  !
`World Congresses
`of Gastroenterology, Vienna 1998.
`A  .  #  .  H $$)
`Inflamm Bowel Dis 2000; 6: 8-15.
`7= ,, I0 ;&+()* 
`24
`Sachar DB, Andrews HA, Farmer RG, et al. Proposed classi-
`;< ! I@01@ ,#23456/ 
`fication of patient subgroups in Crohn’s disease. Gastroenterol
`?  -.!" # 
`Int 1992; 5: 141-54.
`7$$;& (<* <
`25
`Kryneiski EY, Evans WE. Genetic polymorphism of thiopurine
`; D 

J

 A

# ,!, !
`S-methyltransferase: molecular mechanisms and clinical
`
` ,!   (,   ,! ,   
`importance. Pharmacology 2000; 61: 136-46.
`, /! ,  . ;&+('+*<+
`26
`ColombelJF, Ferrari N, Debuysere H,et al. Genotypic analysis
`;+  ,-
` - 123456#   
`of thiopurine S-methyliransferase in patients with Crohn’s
`! ,!    0!!"
`disease and severe myelosuppression during azathioprine
`    ,   . F !
`therapy. Gastroenterology 2000; 118: 1025-30.
`!  #  . ;&)(; *'
`27
`Corominas H, Domenech M,Gonzalez D,et al. Allelic variants
`;% , 1,!#F F23456@    
`of the thiopurine S-methyltransferase deficiency in patients
`!! ,!   ?  
`with ulcerative colitis and in healthy controls. Am J Gast-
`0!    ! !  @,
`# 
`roenterol 2000; 95: 2313-7.
` ;&$ (;''*%
`28
`Armstrong VW, Oellerich M. New developments in the
`;) @,. HA ! 0  , !
`immunosuppressive drug monitoring of cyclosporine, tacrol-
`,,.,.    
`imus, and azathioprine. Clin Biochem 2001; 34: 9-16.
`,  F ! I!, ;&'<($*+
`29
`and
`Sandborn WJ. Rational
`dosing
`of
`azathioprine
`;$ - A
`   .  F ! 
`6-mercaptopurine. Gut 2001; 48: 591-2.
`+, #;&<)( $*;
`
`30
`Weitzman JB. Bowel disease gets the Nod. Trends Mol Med
`' AF, 
`II0  .!9 
`2001; 7: 335-6.
`;&%('' *+
`31
`the Crohn’s
`Beutler B. Autoimmunity and apoptosis:
`' I  I @,,  ( ! !"
`connection. Immunity 2001; 15: 5-14.
`7,, ;& ( *<
`32
`O’Neill L. Crohn’s disease gene is given the NOD. Trends
`'; " G!" .. !9
`Immunol 2001; 22: 418-9.
`7,, ;&;;(<)*$
`33
`Pestell K. New targets for Crohn’s disease. Trends Pharmacol
`'' / D0 .!" 9/! , 
`Sci 2001; 22: 342.
`
` ;&;;('<;
`34
`Hampe J, Cuthbert A, Croucher PJ,
`et al. Association
`'< 1 ,
`!-@! /
`23456@ 
`between insertion mutation in NOD2 gene and Crohn’s
`-0  ,   ; .  !"
`disease in German and British populations. Lancet 2001;
`  #,  I!  G ;&
`357: 1925-8.
`' %($; *)
`35
`Van Heel DA, McGovern DP, Jewell DP. Crohn’s disease:
`' H  1 @# /
`0 /!" (
`genetic susceptibility, bacteria, and innate immunity. Lancet
`.-  -    ,, G 
`2001; 357: 1902-4.
`;&' %($;*<
`36
`Frankish H. Crohn’s geneidentified. Lancet 2001; 357: 1678.
`'+  !1!".?G ;&' %(+%)
`37
`Ogura Y, Bonen DK, Inochara N,et al. A frameshift mutation
`'% . JID7!  23456@ ,!, 
`in NOD2 associated with susceptibility to Crohn’s disease.
` ;  0!-  !" 
`Nature 2001; 411: 603-6.
` ;&<(+'*+
`38
`Hugot JP, Chamaillard M, Zouali H,et al. Association of NOD2
`') 1.
`/! ,  K 123456@ ;
`leucine-rich repeat variants with susceptibility to Crohn’s
` !    0! -  !"
`disease. Nature 2001; 411: 599-603.
`  ;&<( $$*+'
`39
`Todd JA. Human genetics. Tackling common disease. Nature
`'$ 9
`@1, .9  .,,  
`2001; 411(537): 539.
`;&<8 '%:( '$
`40
`Moniteleone G, Kumberova A, Croft NM, McKenzie C, Steer
`<  #D,- @DF 
`HW, MacDonald TT. Blocking Smad7 restores TGEF-81
`1A   99I . , %  9#L
`signaling in chronic inflammatory bowel disease. J Clin Invest
`. .!= ,,  -0  
` 7
`2001; 108: 601-9.
`;&)(+*$
`41
`Fiocchi C. TGF-8/Smad signaling defects in inflammatory
`< !9#LM ,  . . = ,, 
`bowel disease: mechanisms and possible novel therapies for
`-0  (,! , -  ! 
`chronic inflammation. J Clin Invest 2001; 108: 523-6.
`!= ,, 
` 7;&)( ;'*+
`42
`Schiffer M, Bitzer M, Roberts IS, et al. Apoptosis in podocytes
`<; !IF-7 23456@ 
`induced by TGF-8 and Smad7. J Clin Invest 2001; 108:
`- 9#L  , %
`  7;&)(
`807-16.
`)%*+
`43
`Barbara G, Xing Z, Hogaboam CM, Gauldie J, Collins SM.
`<' I -  #N.K1. - , #  
`  
`Interleukin 10 gene transfer prevents experimental colitis in
`7 . >,  
`rats. Gut 2000; 46: 344-9.
` #;&<+('<<*$
`44
`Kitani A, Fuss IJ], Nakamura K, Schwartz OM,Usui T, Strober
`<< D @7
`  , D !0 FB9 -
`W.Treatment of experimental (Trinitrobenzene sulfonic acid)
`A9 ,>, 89-F  :
`colitis by intranasal administration of transforming growth
` -    ,  ,..0!
`factor (TGF)-81 plasmid. TGF-81-mediated suppression of T
` 89#:L ,9#L, 9
`helper cell
`type 1 response occurs by interleukin (IL)-10
`!    -   87G:
`induction and IL-12 receptor 82 chain downregulation. J Exp
` 7G;L;! 0. 
`

>
`Med 2000; 192: 41-52.
`;&$;(<* ;
`45
`Flotte TR. Recombinant adeno-associated virus vectors for
`<  9,-    
`cystic fibrosis gene therapy. Curr Opin Mol Ther 2001; 3:
`
` ?-.!   9!;&'(
`497-502.
`<$%* ;
`
`© 2002 Blackwell Science Ltd, Aliment Pharmacol Ther 16 (Suppl. 4), 53-58
`O ;;I 0 GP5QR2S3TU4VR4WX5YU2VZ[8  <: '* )
`
`